Oral contraceptives typically have little impact on libido

Oral contraceptives typically have little impact on libido
For most women, oral contraceptives do not affect libido, but health care providers should be aware that some women may experience negative effects on sexual function, according to a study published online July 12 in The Journal of Sexual Medicine.

(HealthDay) -- For most women, oral contraceptives do not affect libido, but health care providers should be aware that some women may experience negative effects on sexual function, according to a study published online July 12 in The Journal of Sexual Medicine.

Lara J. Burrows, M.D., from Georgetown University in Washington D.C., and colleagues searched and reviewed the literature to investigate the effects of hormonal contraceptives on sexual function in women.

The researchers found that, while side effects such as breast tenderness and weight gain are well documented, sexual side effects are not as well studied. The majority of the literature pertains to combined oral contraceptives. In the literature, mixed effects on libido are reported, with a small percentage of women experiencing an increase or a decrease, and the majority being unaffected. But, for the individual woman who is negatively affected this can have substantial impact on her quality of life and sexuality.

" must be aware that can have negative effects on female sexuality so they may counsel and care for their patients appropriately," Burrows and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.